A Randomised study to evaluate the efficacy, safety and durability of Ruxolitinib and Tofacitinib for the treatment of Alopecia Areata
Latest Information Update: 24 Jun 2019
At a glance
- Drugs Ruxolitinib (Primary) ; Tofacitinib (Primary)
- Indications Alopecia; Alopecia areata
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 24 Jun 2019 New trial record